Denosumab: a breakthrough in treatment of giant-cell tumour of bone?
Maurice
M
Balke
Jendrik
J
Hardes
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D000069448:Denosumab; D018212:Giant Cell Tumor of Bone / Q000188:drug therapy*; D006801:Humans; D053245:RANK Ligand / Q000037:antagonists & inhibitors* / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D053245:RANK Ligand; D000069448:Denosumab